Innate Immunity
Innate Immunity(先天免疫)
Innate Immunity 相关产品(557)
- GC52154Inflammasome Inhibitor 4bCAS: 2768759-64-2纯度: >98.00%
An inhibitor of NLRP3 inflammasome activation
- GC52318Oleic Acid-13C5CAS: 1255644-48-4纯度: >95.00%
An internal standard for the quantification of oleic acid
- GC52326Biotin-PEG4-LL-37 (human) (trifluoroacetate salt)纯度: >90.00%
A biotinylated and pegylated form of LL-37
- GC52329Betamethasone-d5CAS: 2244574-92-1纯度: >99.00%
An internal standard for the quantification of betamethasone
- GC52346IDR 1002 (trifluoroacetate salt)纯度: >95.00%
A synthetic cationic innate defense regulator peptide
- GC52363Citrullinated Histone H3 (R2 + R8 + R17) (2-22)-biotin Peptide
A biotinylated and citrullinated histone H3 peptide
- GC52367Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide纯度: >99.00%
A biotinylated and citrullinated mutant vimentin peptide
- GC52370Citrullinated Vimentin (R144) (139-159)-biotin Peptide纯度: >98.00%
A biotinylated and citrullinated vimentin peptide
- GC52384NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)纯度: >95.00%
A cell-permeable form of NFAT inhibitor
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC52027 | Isolariciresinol | 548-29-8 | >98.00% | |
A lignan with diverse biological activities | ||||
| GC52074 | Loratadine N-oxide | 165739-62-8 | >95.00% | |
A metabolite of loratadine | ||||
| GC52084 | YSK05 | 1318793-78-0 | >90.00% | |
An ionizable cationic amino lipid | ||||
| GC52101 | Brazilein | 600-76-0 | >95.00% | |
A phytochemical with diverse biological activities | ||||
| GC52127 | Pexiganan (acetate) | 172820-23-4 | >98.00% | |
An antimicrobial peptide | ||||
| GC52154 | Inflammasome Inhibitor 4b | 2768759-64-2 | >98.00% | |
An inhibitor of NLRP3 inflammasome activation | ||||
| GC52197 | RSC-3388 | 337307-06-9 | >95.00% | |
cPLA 2 inhibitor | ||||
| GC52270 | Pranoprofen-13C-d3 | - | >99.00% | |
An internal standard for the quantification of pranoprofen | ||||
| GC52291 | KAS 08 | 203861-20-5 | >95.00% | |
A STING activator | ||||
| GC52307 | CAY10790 | 107813-86-5 | >98.00% | |
A CysLT 1 receptor antagonist and GPBAR1 agonist | ||||
| GC52318 | Oleic Acid-13C5 | 1255644-48-4 | >95.00% | |
An internal standard for the quantification of oleic acid | ||||
| GC52326 | Biotin-PEG4-LL-37 (human) (trifluoroacetate salt) | - | >90.00% | |
A biotinylated and pegylated form of LL-37 | ||||
| GC52329 | Betamethasone-d5 | 2244574-92-1 | >99.00% | |
An internal standard for the quantification of betamethasone | ||||
| GC52334 | ENPP1 Inhibitor 4e | - | >98.00% | |
An ENPP1 inhibitor | ||||
| GC52342 | P4pal10 (trifluoroacetate salt) | - | >98.00% | |
A PAR4 and FPR2 antagonist and an FFAR2 agonist | ||||
| GC52343 | 113-O12B | 2803699-72-9 | >98.00% | |
An ionizable cationic lipidoid | ||||
| GC52346 | IDR 1002 (trifluoroacetate salt) | - | >95.00% | |
A synthetic cationic innate defense regulator peptide | ||||
| GC52363 | Citrullinated Histone H3 (R2 + R8 + R17) (2-22)-biotin Peptide | - | - | |
A biotinylated and citrullinated histone H3 peptide | ||||
| GC52364 | Vimentin (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated vimentin peptide | ||||
| GC52367 | Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide | - | >99.00% | |
A biotinylated and citrullinated mutant vimentin peptide | ||||
| GC52370 | Citrullinated Vimentin (R144) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated and citrullinated vimentin peptide | ||||
| GC52371 | Vimentin (G146R) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated mutant vimentin peptide | ||||
| GC52384 | NFAT Inhibitor (cell-permeable) (trifluoroacetate salt) | - | >95.00% | |
A cell-permeable form of NFAT inhibitor | ||||
| GC52394 | LC10 | - | >98.00% | |
A lipidoid derivative of lithocholic acid | ||||